ADC04 Liptáková, Adriána - Siegfried, Leonard - Rosocha, Ján - Podracká, Ľudmila - Bogyiová, E. - Kotulová, Daniela: A family outbreak of haemolytic uraemic syndrome and haemorrhagic colitis caused by verocytotoxigenic Escherichia coli O157 from unpasteurised cow´s milk in Slovakia

In: Clinical Microbiology and Infection. - Vol. 10, No. 6 (2004), pp. 576-578. - ISSN 1198-743X

Journal Indicator: IF (JCR) 2004=2.361

Quartile Q:

wos-jcr -- Q2 [Infectious diseases] -- 2004

wos-jcr -- Q2 [Microbiology] -- 2004

scimago-sjr -- Q2 [Infectious Diseases] -- 2004

scimago-sjr -- Q1 [Medicine (miscellaneous)] -- 2004

scimago-sjr -- Q2 [Microbiology (medical)] -- 2004

The paper was written during my postgraduate studies, one of the goals of which was focused on the implementation of a laboratory algorithm for the capture of verocytotoxigenic E.coli (VTEC).

In 2003, we used PCR diagnostics for the first time in Slovakia to detect genes encoding Shiga toxins, enterohemolysin and adhesion protein.

This study reports the first cases of hemolytic-uremic syndrome and hemorrhagic colitis in Slovakia caused by VTEC O157.

Thanks to the established algorithm, we detected a familial epidemic of verocytotoxigenic Escherichia coli O157 (VTEC) infection involving nine individuals from one extended family that occurred in eastern Slovakia. Three children suffered from hemolytic-uremic syndrome, two children had bloody diarrhea, and four adults were asymptomatic carriers. Fourteen non-sorbitol-fermenting E. coli O157 isolates containing the vtx2, eae, and ehxA genes were obtained. Verocytotoxin 2 activity was demonstrated in all 14 isolates.

We worked very closely with pediatricians, epidemiologists, and the veterinary administration. After epidemiological surveillance, unpasteurized cow's milk was identified as the source of infection.

The results of the work helped to implement a new microbiological diagnostic protocol for VTEC infections in Slovakia.

ADC03 Birošová, Eva - Siegfried, Leonard - Kmeťová, Marta - Makara, A. - Ostró, Alexander -Grešová, A. - Urdzík, P. - Liptáková, Adriána - Molokáčová, Mária - Bártl, R. (aut) - Valanský, L.: Detection of virulence factors in alpha - haemolytic Escherichia coli strains isolated from various clinical materials

In: Clinical Microbiology and Infection. - Vol. 10, No. 6 (2004), pp. 569-573. - ISSN 1198-743X

Journal Indicator:IF (JCR) 2004=2.361

Quartile Q:

wos-jcr -- Q2 [Infectious diseases] -- 2004

wos-jcr -- Q2 [Microbiology] -- 2004

During my postgraduate studies, I was part of a research team that established molecular biological methods for the detection of virulence factors by detecting their genes. A total of 201 α-hemolytic Escherichia coli isolates from various clinical materials (urine samples and vaginal and rectal swabs) were examined by PCR for the presence of genes for the virulence factors α-hemolysin (hly), cytotoxic necrotizing factor type 1 (cnf1), P-fimbriae (pap), S/F1C-fimbriae (sfa/foc), aerobactin (aer) and afimbrial adhesin (afal). Among vaginal isolates, 96% were positive for cnf1 compared with 80% of urine strains (p 0.02) and 63% of rectal strains (p 0.0001). Similarly, DNA sequences specific for sfa/foc were found in 97% of vaginal isolates compared with 75% of rectal strains (p 0.004). The afa1 and aer genes were more associated with rectal α-hemolytic E. coli strains than with extraintestinal isolates. The results suggest that CNF1 and/or S/F1C-fimbriae contribute to the colonization and persistence of α-hemolytic E. coli strains in the vaginal environment. Statistical analysis revealed an increased abundance of cnf1 and sfa/foc in E. coli isolates from vaginal swabs compared with isolates from urine or rectal swabs.

This finding was significant for three reasons. First, S-fimbriae are known to contain a key virulence factor in the pathogenesis of neonatal meningitis caused by E. coli. Therefore, the persistence of S-fimbriae α-hemolytic E. coli strains in the vagina of pregnant women may expose newborns to a higher risk of infection. Second, E. coli is the most common pathogen isolated from patients with bacterial prostatitis. Several authors have observed an increased proportion of necrotoxigenic E. coli strains in patients with bacterial prostatitis. Therefore, vaginal transmission of necrotoxigenic E. coli strains could expose sexual partners to the risk of prostatic infection. Third, women often suffer from an increased susceptibility to recurrent urinary and genital tract infections associated with uropathogenic E. coli strains.

ADC03 Birošová, Eva - Siegfried, Leonard - Kmeťová, Marta - Makara, A. - Ostró, Alexander -Grešová, A. - Urdzík, P. - Liptáková, Adriána - Molokáčová, Mária - Bártl, R. (aut) - Valanský, L.: Detection of virulence factors in alpha - haemolytic Escherichia coli strains isolated from various clinical materials

In: Clinical Microbiology and Infection. - Vol. 10, No. 6 (2004), pp. 569-573. - ISSN 1198-743X

Journal Indicator:IF (JCR) 2004=2.361

Quartile Q:

wos-jcr -- Q2 [Infectious diseases] -- 2004

wos-jcr -- Q2 [Microbiology] -- 2004

During my postgraduate studies, I was part of a research team that established molecular biological methods for the detection of virulence factors by detecting their genes. A total of 201 α-hemolytic Escherichia coli isolates from various clinical materials (urine samples and vaginal and rectal swabs) were examined by PCR for the presence of genes for the virulence factors α-hemolysin (hly), cytotoxic necrotizing factor type 1 (cnf1), P-fimbriae (pap), S/F1C-fimbriae (sfa/foc), aerobactin (aer) and afimbrial adhesin (afal). Among vaginal isolates, 96% were positive for cnf1 compared with 80% of urine strains (p 0.02) and 63% of rectal strains (p 0.0001). Similarly, DNA sequences specific for sfa/foc were found in 97% of vaginal isolates compared with 75% of rectal strains (p 0.004). The afa1 and aer genes were more associated with rectal α-hemolytic E. coli strains than with extraintestinal isolates. The results suggest that CNF1 and/or S/F1C-fimbriae contribute to the colonization and persistence of α-hemolytic E. coli strains in the vaginal environment. Statistical analysis revealed an increased abundance of cnf1 and sfa/foc in E. coli isolates from vaginal swabs compared with isolates from urine or rectal swabs.

This finding was significant for three reasons. First, S-fimbriae are known to contain a key virulence factor in the pathogenesis of neonatal meningitis caused by E. coli. Therefore, the persistence of S-fimbriae α-hemolytic E. coli strains in the vagina of pregnant women may expose newborns to a higher risk of infection. Second, E. coli is the most common pathogen isolated from patients with bacterial prostatitis. Several authors have observed an increased proportion of necrotoxigenic E. coli strains in patients with bacterial prostatitis. Therefore, vaginal transmission of necrotoxigenic E. coli strains could expose sexual partners to the risk of prostatic infection. Third, women often suffer from an increased susceptibility to recurrent urinary and genital tract infections associated with uropathogenic E. coli strains.

ADC10 Dražilová, Sylvia - Janičko, Martin - Skladaný, Ľubomír - Kristian, Pavol - Oltman, Marián - Szántová, Mária - Krkoška, ​​Dušan - Mazuchová, Eva - Piesecká, Ľubica - Vahalova, Veronika - Rác, Marek - Schréter, Ivan - Virág, Ladislav - Koller, Tomáš - Liptáková, Adriána - Ondrášová, Miriam (5%) - Jarčuška, Peter : Glucose metabolism changes in patients with chronic hepatitis C Treated with direct acting antivirals

In: Canadian Journal of Gastroenterology & Hepatology [electronic document]. - Roč. 2018 (2018), p. [1-10], art. no. 6095097 [print]. - ISSN (print) 2291-2789

URL: https://www.hindawi.com/journals/cjgh/2018/6095097/

Journal Indicator: IF (JCR) 2018=1.714

Quartile Q:

scimago-sjr -- Q2 [Medicine (miscellaneous)] -- 2018

The paper was written during my postdoctoral studies. Chronic hepatitis C is a systemic disease and type 2 diabetes mellitus (T2DM) is one of the more common extrahepatic manifestations. The aims of this study were (i) to investigate the prevalence of impaired fasting glucose (IFG) and T2DM in patients with chronic hepatitis C, (ii) to investigate the impact of direct-acting antiviral (DAA) treatment on glycemia, and (iii) to investigate factors that modulate the effect of DAA treatment on glycemia in patients with chronic hepatitis C. We conducted a longitudinal retrospective observational study of patients undergoing DAA treatment for chronic hepatitis C. Data on glycemia, history of diabetes, hepatitis C virus, treatment, and liver status including elastography were obtained at baseline (before treatment), at the end of treatment, and 12 weeks after treatment. Patients were treated with different regimens of direct-acting antivirals.

Results. We enrolled 370 patients; 45.9% had F4 fibrosis. At baseline, the prevalence of T2DM increased with the degree of fibrosis (F0-F2 14.4%, F3 21.3% and F4 31.8%, p=0.004). Fasting glycemia also increased with the degree of fibrosis (F0-F2 5.75±0.18 F3 5.84±0.17 and F4 6.69±0.2 mmol/l, p=0.001). We observed a significant decrease in glycemia after treatment in all patients, but in patients without T2DM or IFG from 6.21±0.12 to 6.08±0.15 mmol/l (p=0.002). The decrease was also visible in patients who had already been treated and in patients with Child-Pugh A cirrhosis. We confirmed that the prevalence of T2DM or IFG increases in patients with chronic hepatitis C with the degree of fibrosis. Predictive factors for T2DM were, in addition to F4 fibrosis, older age and BMI. A significant decrease in fasting blood glucose after DAA treatment was observed in the entire population and in subgroups of patients with T2DM, IFG, cirrhosis and treated patients.

Also based on this study, antiviral therapy against HCV with an efficacy of about 99.9% became available and fully reimbursed in Slovakia, which significantly contributed to reducing the risks associated with untreated HCV infection.

V310 Ficik, Jozef - Andrezál, Michal - Drahovská, Hana - Böhmer, Miroslav - Szemes, Tomáš (aut) - Liptáková, Adriána - Slobodníková, Lívia: Carbapenem-Resistant Klebsiella pneumoniae in COVID-19 Era-Challenges and Solutions

In: Antibiotics. - Vol. 12, No. 8 (2023), pp. [1-16], art. no. 1285. - ISSN (online) 2079-6382

Journal indicator:IF (JCR) 2022=4.8

Quartile Q:

wos-jcr -- Q1 [Pharmacology & pharmacy] -- 2022

wos-jcr -- Q2 [Infectious diseases] -- 2022

In 2022, we successfully accredited the 3rd level of postgraduate study in the field of Medical Microbiology and Immunology. The work is the result of scientific research by one of our first doctoral students at the workplace.

The COVID-19 period brought new medical challenges, which, together with nosocomial bacterial infections, meant a huge burden for the healthcare system. One of the most alarming nosocomial threats was carbapenem-resistant Klebsiella pneumoniae (CRKP). Monitoring the incidence of CRKP and antimicrobial resistance globally and locally is vital. In a retrospective study, the incidence of CRKP was determined in the Central Military Hospital in Ružomberok in the period before COVID-19 (2017–2019) and the COVID-19 pandemic (2020–2022). The relative incidence of CRKP increased significantly during the COVID-19 period – 4.8 times, from 0.18 to 0.76%. At the same time, 47% of CRKP-positive patients also had COVID-19. 26 KPC isolates and 69 NDM-producing isolates were identified. CRKP isolated in 2022 were subjected to whole-genome sequencing and their susceptibility was tested to cefiderocol, ceftazidime–avibactam, imipenem–relebactam and meropenem–vaborbactam with excellent results. KPC-producing isolates were also highly susceptible to colistin (92%). NDM isolates revealed lower susceptibility rates, including only 57% susceptibility to colistin. ST-307 was predominant in KPC and ST-11 in NDM isolates. Despite the excellent activity of new antimicrobials, a rational antibiotic policy supported by complementary therapy and strict anti-epidemic measures must be strictly followed.

The results of the study support the entry of new drugs and their availability for the treatment of serious nosocomial infections.

The work was published in a special issue of the journal Antibiotics “Strategies for Combatting Multidrug-Resistant and Extensively Drug-Resistant Bacteria: Current Challenges and Future Prospects”, in which I was a guest editor.

V310 Ficik, Jozef - Andrezál, Michal - Drahovská, Hana - Böhmer, Miroslav - Szemes, Tomáš (aut) - Liptáková, Adriána - Slobodníková, Lívia: Carbapenem-Resistant Klebsiella pneumoniae in COVID-19 Era-Challenges and Solutions

In: Antibiotics. - Vol. 12, No. 8 (2023), pp. [1-16], art. no. 1285. - ISSN (online) 2079-6382

Journal indicator:IF (JCR) 2022=4.8

Quartile Q:

wos-jcr -- Q1 [Pharmacology & pharmacy] -- 2022

wos-jcr -- Q2 [Infectious diseases] -- 2022

In 2022, we successfully accredited the 3rd level of postgraduate study in the field of Medical Microbiology and Immunology. The work is the result of scientific research by one of our first doctoral students at the workplace.

The COVID-19 period brought new medical challenges, which, together with nosocomial bacterial infections, meant a huge burden for the healthcare system. One of the most alarming nosocomial threats was carbapenem-resistant Klebsiella pneumoniae (CRKP). Monitoring the incidence of CRKP and antimicrobial resistance globally and locally is vital. In a retrospective study, the incidence of CRKP was determined in the Central Military Hospital in Ružomberok in the period before COVID-19 (2017–2019) and the COVID-19 pandemic (2020–2022). The relative incidence of CRKP increased significantly during the COVID-19 period – 4.8 times, from 0.18 to 0.76%. At the same time, 47% of CRKP-positive patients also had COVID-19. 26 KPC isolates and 69 NDM-producing isolates were identified. CRKP isolated in 2022 were subjected to whole-genome sequencing and their susceptibility was tested to cefiderocol, ceftazidime–avibactam, imipenem–relebactam and meropenem–vaborbactam with excellent results. KPC-producing isolates were also highly susceptible to colistin (92%). NDM isolates revealed lower susceptibility rates, including only 57% susceptibility to colistin. ST-307 was predominant in KPC and ST-11 in NDM isolates. Despite the excellent activity of new antimicrobials, a rational antibiotic policy supported by complementary therapy and strict anti-epidemic measures must be strictly followed.

The results of the study support the entry of new drugs and their availability for the treatment of serious nosocomial infections.

The work was published in a special issue of the journal Antibiotics “Strategies for Combatting Multidrug-Resistant and Extensively Drug-Resistant Bacteria: Current Challenges and Future Prospects”, in which I was a guest editor.

FAI02 Liptáková, Adriána - Predný, Ján - Buc, Milan - Slobodníková, Lívia - Jalili, Nasir - Krčméry, Vladimír - Koreň, Ján: Medical Microbiology. - 1st ed. - Bratislava : Herba, 2019. - 952 p. [145.03 AH] [print]. - (Dieškova edícia ; vol. 8) ISBN 978-80-89631-91-9

textbook for universities

Microbiology is a basic medical field that records constant interest from scientists and doctors. The first edition of the book (until 2019, there was no Slovak textbook of medical microbiology) reached readers just a few weeks before the outbreak of the pandemic caused by SARS-CoV-2, which significantly affected our everyday lives. The book sold out in less than a year, and the team of authors reunited and prepared a high-quality textbook, which also includes innovative chapters on the impact of the coronavirus pandemic. Microbiology is one of the basic undergraduate subjects for medical students. The basics of bacteriology, virology, mycology and parasitology, together with the basics of anti-infective therapy, are the building blocks for all additional clinical subjects such as internal medicine, surgery, pediatrics, gynecology and obstetrics, infectious diseases and others. New knowledge in the field of molecular biology, immunology, diagnostics and treatment of infectious diseases has brought great progress in medical microbiology. The website www.lekarskamikrobiologia.eu, which is part of the book, has already become a commonly used study material. The medical microbiology textbook serves medical students so that they can properly manage a patient with a suspected infectious disease in their medical practice. The textbook, together with the e-learning solution, provides a summary of the latest knowledge in medical microbiology. This knowledge is reflected in the higher quality of the educational process of students of medical faculties not only in Bratislava but also at other medical faculties in Slovakia. The connection of the textbook and the virtual space allows for the updating and accessibility of the latest knowledge in microbiological science. Testing in an electronic environment from home increases student compliance and makes the demanding medical field more attractive. Students can verify their knowledge acquired in lectures, practical exercises and by studying mandatory literature using control questions assigned to clinical cases.

P103 Blažeková, Mária - Botek, Rudolf - Buc, Milan - Bukovinová, Pavlína - Czirfusová, Monika - Čurová, Katarína - Deglovič, Juraj - Dibalová, Hana - Drahovská, Hana - Drgoňa, Ľuboš - Dubinová, Martina - Gdovinová, Zuzana - Holá, Veronika - Horniačková, Miroslava - Hubenáková, Zuzana -Hučková, Daniela - Jalili, Nasir - Kónyová, Zuzana - Koreň, Ján - Krčméry, Vladimír - Kristian, Pavol - Liptáková, Adriána - Lisalová, Magdaléna - Líšková, Anna - Neuschlová, Martina - Nováková, Elena - Novotný, Martin - Ondriska, František - Piecková, Elena - Poľanova, Monika - Porvazník, Igor - Růžička, Filip - Sabaka, Peter - Schréter, Ivan - Slobodníková, Lívia - Solovič, Ivan (aut) - Straka, Marek - Šimaljaková, Mária - Staneková, Danica: Medical Microbiology. - 2nd supplementary ed. - Bratislava: Herba, 2023. - 771 p. [118.4 AH] [print]. - (Dieškovaedícia ; vol. 10), ISBN 978-80-8229-027-4

textbook for universities

Microbiology is a basic medical field that has been of constant interest to scientists and doctors. The first edition of the book (until 2019, there was no Slovak textbook of medical microbiology) reached readers just a few weeks before the outbreak of the SARS-CoV-2 pandemic, which has significantly affected our everyday lives. The book sold out in practically less than a year, and the team of authors reunited and prepared a high-quality teaching text that also includes innovative chapters touching on the impact of the coronavirus pandemic. Microbiology is one of the elementary undergraduate subjects for medical students. The basics of bacteriology, virology, mycology and parasitology, together with the basics of anti-infective therapy, are the building blocks for all additional clinical subjects such as internal medicine, surgery, pediatrics, gynecology and obstetrics, infectology and others. New knowledge in the field of molecular biology, immunology, diagnostics and treatment of infectious diseases has brought great progress in medical microbiology. The website www.lekarskamikrobiologia.eu, which is part of the book, has already become a commonly used study material. The textbook of medical microbiology serves medical students to know how to properly manage a patient with a suspected infectious disease in their medical practice. The textbook, together with an e-learning solution, provides a summary of the latest knowledge in medical microbiology. This knowledge is reflected in a higher quality of the educational process of medical faculty students not only in Bratislava but also at other medical faculties in Slovakia. The connection between the textbook and the virtual space allows for updating and making available the latest knowledge in microbiological science. Testing in an electronic environment from home increases student compliance and makes the demanding medical field more attractive. Students can verify their knowledge acquired in lectures, practical exercises and by studying mandatory literature using control questions assigned to clinical cases.

Matteo Boattini, Gabriele Bianco, Paulo Bastos, Viktoria Eirini Mavromanolaki, Sofia Maraki, Anastasia Spiliopoulou, Vasileios Kakouris, Yordan Kalchev, Ana Budimir, Branka Bedenić, Zana Rubic, Monica Licker, Corina Musuroi, Emese Juhász, Katalin Kristóf, Mateja Pirs, Ivana Velimirovic, Michael Berktold, Adriána Liptáková, Adriana Krajcikova, Pavel Drevinek, Anezka Gryndlerova, Monika Brzychczy-Wloch, Aldona Olechowska-Jarząb, Filip Bielec, Małgorzata Brauncajs, Edyta Podsiadly, Grażyna Nurzyńska, Patrycja Zalas-Więcek, Kristian Riesbeck, Hanna-Sofia Andersson, Tone Tønjum, Johan Christian Berild, Truls Michael Leegaard, Asger Nellemann Rasmussen, Kristian Schønning, Stefan Glöckner, Jürgen Rödel, Mohamed Tarek Badr, Georg Alexander Häcker, Denise Stark, Axel Hamprecht, Anna Dudakova, Jonathan Jantsch, Stefano Mancini, Chantal Quiblier, Damien Jacot, Gilbert Greub, Tiziano Ferniani, Simone Ambretti, Maddalena Calvo, Stefania Stefani, Rogier Schade, Erlangga Yusuf, Stefanie van Kleef-van Koeveringe, Sarah Vandamme, Alexia Verroken, Hector Rodriguez-Villalobos, François Duigou, Stéphane Corvec, Pauline Floch, Clémence Massip, Delphine Chainier, Olivier Barraud, Marie-Bossuète Louissaint, Assaf Mizrahi, Saied Ali, Maeve Doyle, Clarice Egan, Sinead McNicholas, Javier Colomina-Rodriguez, Ignacio Torres, Raul Gilarranz Luengo, Maria Nieves Larrosa Escartín, Maria Belen Viñado Perez, Ana Verónica Halperin, Sergio Fuente García, Rafael Cantón, Miguel Seruca, Vasco Santos Mendes, Dinah Carvalho, Rossana Cavallo, José Melo Cristino, Cristina Costa,

Diagnostic and epidemiological landscape of anaerobic bacteria in Europe, 2020–2023 (ANAEuROBE),

International Journal of Antimicrobial Agents,

Volume 65, Issue 6,

2025,

107478,

ISSN 0924-8579,

https://doi.org/10.1016/j.ijantimicag.2025.107478.

(https://www.sciencedirect.com/science/article/pii/S0924857925000354)

Abstract: Introduction

Despite being implicated in a wide spectrum of community- and healthcare-acquired infections, anaerobes have not yet been incorporated into systematic surveillance programs in Europe.

Methods

We conducted a multicentre retrospective observational study analysing all anaerobic strains isolated from blood cultures in 44 European Hospital Centres over a 4-y period (2020–2023). Diagnostic approach, epidemiology, and antimicrobial susceptibility according to EUCAST v. 15.0 were investigated.

Results

Our study included 14,527 anaerobes, most of which were Gram-positive (45%) or Gram-negative (40%) bacilli. MALDI-TOF coupled to mass spectrometry was the most widely used tool for species identification (98%). Antimicrobial susceptibility testing was performed in the vast majority of centres, using mostly gradient diffusion strip (77%) and disk diffusion (45%) methods according to EUCAST guidelines. The most prevalent species were Cutibacterium acnes (18.7%), Bacteroides fragilis (16.3%), Clostridium perfringens (5.3%), Bacteroides thetaiotaomicron (4.2%), Fusobacterium nucleatum (3.5%), and Parvimonas micra (3.4%). C. acnes showed high resistance to benzylpenicillin (18%), clindamycin (39%), and imipenem (19% and 13% by MIC methods and disk diffusion, respectively). B. fragilis showed high resistance to amoxicillin/clavulanate (24%), piperacillin/tazobactam (22% and 14% by MIC methods and disk diffusion, respectively), clindamycin (22% by both MIC methods and disk diffusion), meropenem (13%), and metronidazole (10%, only by disk diffusion). A similar resistance pattern was observed in B. thetaiotaomicron, Bacteroides ovatus, and Parabacteroides distasonis. C. perfringens showed high resistance to clindamycin (69% and 45% by MIC methods and disk diffusion, respectively), while benzylpenicillin and metronidazole maintained over 90% activity. F. nucleatum showed high resistance to benzylpenicillin (11%), while Fusobacterium necrophorum showed alarming rates of resistance to clindamycin (12%), meropenem (16%) and metronidazole (11%).

Conclusions

This study presented an up-to-date analysis of the diagnostics and epidemiology of anaerobic bacteria in Europe, providing insights for future comparative analyses and the development of antimicrobial diagnostic and management strategies, as well as the optimization of current antibiotic treatments.

Keywords: Anaerobes; Antimicrobial resistance; Bacteroides; Blood culture; Clostridium; Sepsis

Jalali, Y.; Liptáková, A.; Jalali, M.; Payer, J. Moving toward Extensively Drug-Resistant: Four-Year Antimicrobial Resistance Trends of Acinetobacter baumannii from the Largest Department of Internal Medicine in Slovakia. Antibiotics 2023, 12, 1200. https://doi.org/10.3390/antibiotics12071200

ADC04 Liptáková, Adriána - Siegfried, Leonard - Rosocha, Ján - Podracká, Ľudmila - Bogyiová, E. - Kotulová, Daniela: A family outbreak of haemolytic uraemic syndrome and haemorrhagic colitis caused by verocytotoxigenic Escherichia coli O157 from unpasteurised cow´s milk in Slovakia

In: Clinical Microbiology and Infection. - Vol. 10, No. 6 (2004), s. 576-578. - ISSN 1198-743X

Indikátor časopisu: IF (JCR) 2004=2,361

Kvartil Q:

wos-jcr -- Q2 [Infectious diseases] -- 2004

wos-jcr -- Q2 [Microbiology] -- 2004

scimago-sjr -- Q2 [Infectious Diseases] -- 2004

scimago-sjr -- Q1 [Medicine (miscellaneous)] -- 2004

scimago-sjr -- Q2 [Microbiology (medical)] -- 2004

Ohlasy 23, z toho 23 SCI

ADC03 Birošová, Eva - Siegfried, Leonard - Kmeťová, Marta - Makara, A. - Ostró, Alexander -Grešová, A. - Urdzík, P. - Liptáková, Adriána - Molokáčová, Mária - Bártl, R. (aut) - Valanský, L.: Detection of virulence factors in alpha - haemolytic Escherichia coli strains isolated from various clinical materials

In: Clinical Microbiology and Infection. - Vol. 10, No. 6 (2004), s. 569-573. - ISSN 1198-743X

Indikátor časopisu:IF (JCR) 2004=2,361

Kvartil Q:

wos-jcr -- Q2 [Infectious diseases] -- 2004

wos-jcr -- Q2 [Microbiology] -- 2004

Ohlasy 43, z toho 43 SCI

ADC10 Dražilová, Sylvia - Janičko, Martin - Skladaný, Ľubomír - Kristian, Pavol - Oltman, Marián - Szántová, Mária - Krkoška, Dušan - Mazuchová, Eva - Piesecká, Ľubica - Vahalova, Veronika - Rác, Marek - Schréter, Ivan - Virág, Ladislav - Koller, Tomáš - Liptáková, Adriána - Ondrášová, Miriam (5%) - Jarčuška, Peter : Glucose metabolism changes in patients with chronic hepatitis C Treated with direct acting antivirals

In: Canadian Journal of Gastroenterology & Hepatology [elektronický dokument]. - Roč. 2018 (2018), s. [1-10], art. no. 6095097 [print]. - ISSN (print) 2291-2789

URL: https://www.hindawi.com/journals/cjgh/2018/6095097/

Indikátor časopisu: IF (JCR) 2018=1,714

Kvartil Q:

scimago-sjr -- Q2 [Medicine (miscellaneous)] -- 2018

Ohlasy 22, z toho 21 SCI

Lubomira Tothova^ABDEF, Peter Celec^ABCDEFG, Janka Babickova^B, Jana Gajdosova^B, Hend Al-Alami^B, Natalia Kamodyova^B, Hana Drahovska^BG, Adriana Liptakova^G, Jan Turna^G, Julius Hodosy^ABCDEFGDOI: 10.12659/MSM.881844

Med Sci Monit 2011; 17(7): BR173-178

Ohlasy 41, z toho 41 SCI

FAI02 Liptáková, Adriána - Predný, Ján - Buc, Milan - Slobodníková, Lívia - Jalili, Nasir - Krčméry, Vladimír - Koreň, Ján: Lekárska mikrobiológia. - 1. vyd. - Bratislava : Herba, 2019. - 952 s. [145,03 AH] [print]. - (Dieškova edícia ; zv. 8) ISBN 978-80-89631-91-9

učebnica pre vysoké školy

P103 Blažeková, Mária - Botek, Rudolf - Buc, Milan - Bukovinová, Pavlína - Czirfusová, Monika - Čurová, Katarína - Deglovič, Juraj - Dibalová, Hana - Drahovská, Hana - Drgoňa, Ľuboš - Dubinová, Martina - Gdovinová, Zuzana - Holá, Veronika - Horniačková, Miroslava - Hubenáková, Zuzana -Hučková, Daniela - Jalili, Nasir - Kónyová, Zuzana - Koreň, Ján - Krčméry, Vladimír - Kristian, Pavol - Liptáková, Adriána - Lisalová, Magdaléna - Líšková, Anna - Neuschlová, Martina - Nováková, Elena - Novotný, Martin - Ondriska, František - Piecková, Elena - Poľanová, Monika - Porvazník, Igor - Růžička, Filip - Sabaka, Peter - Schréter, Ivan - Slobodníková, Lívia - Solovič, Ivan (aut) - Straka, Marek - Šimaljaková, Mária - Staneková, Danica: Lekárska mikrobiológia. - 2. dopl. vyd. - Bratislava : Herba, 2023. - 771 s. [118,4 AH] [print]. - (Dieškovaedícia ; zv. 10), ISBN 978-80-8229-027-4

učebnica pre vysoké školy

Cultural and Educational Grant Agency of the Ministry of Education, Science, Research and Sports of the Slovak Republic KEGA 002UK-4/2022

2022-2024       Innovation of teaching texts and online files in medical microbiology intended for undergraduate and postgraduate teaching of microbiology at medical faculties through electronic media and simulations

Principal investigator

Cultural and Educational Grant Agency of the Ministry of Education, Science, Research and Sports of the Slovak Republic KEGA004UK-4/2018

2018-2020      Interactive Textbook on Medical Microbiology for Undergraduate Medical Students

Principal Investigator

Agency for the Promotion of Science and Research APVV-18-0171

2019-2022      The importance of new hepatitis B biomarkers for risk stratification and treatment management of patients with chronic HBv infection

Deputy Principal Investigator

Agency for the Promotion of Science and Research APVV-23- 0546

2023-2027 Eradication of multidrug-resistant microorganisms, including carrier strains, in patients using a personalized approach

Principal investigator